Management of Ureteral Calculi Using Ultrasound Guidance: A Radiation Free Approach
1 other identifier
interventional
50
1 country
1
Brief Summary
Kidney stones are very common, and can inflict a significant degree of pain and renal damage. Some stones become obstructed in the ureter, the tube that drains the kidney. In order to remove these stones, an Urologist and their team use fluoroscopic guidance to do so, this involves continuous X-ray. Flouroscopy delivers a significant dose of radiation to the patient, as well as the health care team, which has been shown to have serious health consequences. Previous studies have shown that in certain populations, like pregnant women, stones can be managed using ultrasound guidance. The investigators propose that mid and distal ureteral stones could be managed using ultrasound guidance in conjunction with conventional stone removal techniques (ureteroscopy, lithotripsy, and ureteral stent placement), in lieu of fluoroscopy, thereby minimizing radiation to healthcare staff and patients. The investigators hypothesize that distal ureteral stones can be identified and efficiently fragmented and removed under ultrasound guidance in a safe and effective manner without the use of radiation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2011
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2011
CompletedFirst Submitted
Initial submission to the registry
February 11, 2013
CompletedFirst Posted
Study publicly available on registry
February 15, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2014
CompletedFebruary 10, 2015
February 1, 2015
1.8 years
February 11, 2013
February 9, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Safety of ultrasound guided ureteroscopy
We assess to see if patients had any intraoperative complications during this study, or have any post operative complications as a result of their treatment.
Day1
Secondary Outcomes (1)
To assess the efficacy of ultrasound guided ureteroscopy for management of distal ureteral stones.
post operatively at 4-6wks post op
Study Arms (2)
Control Arm
NO INTERVENTIONThis arm will undergo ureteroscopy using conventional fluoroscopy to guide the procedure and visualize scope position, safety wire status, etc.
Ultrasound guidance
EXPERIMENTALThis arm will have intraoperative ultrasound guidance to determine safety wire position and for scope guidance.
Interventions
Patient will have intraoperative ultrasound .
Eligibility Criteria
You may qualify if:
- Selection criteria will include adult patients with mid and distal ureteral stones ≤8mm, and will be stented prior to presenting for their intervention. Ureteral stenting prior to ureteroscopy is the standard at Dartmouth Hitchcock Medical Center, and both the test and control group will be stented for two weeks prior to their procedure. Initial ureteral stenting will be performed using conventional fluoroscopy at the discretion of the surgeon as this may be in the acute setting and not within the scope of this trial. The mid and distal portion of the ureter refers to the segment of ureter that extends from the upper portion of the sacrum distally to the bladder.
You may not qualify if:
- Patients will be excluded from the trial if they have had surgical resection involving the bladder or ureter, or a history of known ureteral stricture. Also, this is only for adult patients (\>18yo).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire, 03756, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vernon M Pais, MD
Assistant Professor at Dartmouth Hitchcock Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 11, 2013
First Posted
February 15, 2013
Study Start
October 1, 2011
Primary Completion
August 1, 2013
Study Completion
October 1, 2014
Last Updated
February 10, 2015
Record last verified: 2015-02